Gynecologic cancers, which include cancers of the cervix, uterus, ovaries, and vulva, affects individuals of all genders, including those in the LGBTQIA+ community. However, LGBTQIA+ patients often face unique challenges when seeking care for these cancers due to factors such as discrimination, lack of culturally competent care, and barriers to accessing screenings.

Valentina Hoyos Velez, MD, and her team are developing a cutting-edge approach to treatment using a special type of immune cell that could lead to more effective outcomes for individuals battling these cancers.

Dr. Chi fully embodies the 2024 theme for Asian American and Pacific Islander Heritage Month “Advancing Leaders Through Innovation,” making contributions such as his pioneering work in demonstrating the safety and efficacy of incorporating upper abdominal surgical procedures for patients with advanced ovarian cancer.

Addressing funding discrepancies is crucial to ensuring that all cancer survivors receive the resources they need to thrive beyond their diagnosis.

The SGO endorses a journal article that discusses occurrences of endometrial intraepithelial neoplasia (EIN) or atypical endometrial hyperplasia (AEH) developing into endometrial adenocarcinoma, ruling out endometrial cancer to avoid under-treatment when considering non-surgical approaches, and the need for appropriate therapies and vigilant monitoring when opting for non-surgical treatment methods.

Lynn Parker, MD, a gynecologic oncologist at Norton Cancer Institute, joined the FWC #MoveTheMessage initiative as a medical expert, engaging with 2024 Illinois State Fair attendees to raise awareness about gynecologic cancers.

Burnout among gynecologic oncology providers is on the rise, stimulating the need for resources that address wellness for healthcare professionals.

In her professional career, Sara Moufarrij, MD, has made an impact in both basic and translational science, but her dedication to advocacy with a goal of encouraging policymakers to prioritize gynecologic oncology on a national level is something she also finds incredibly important.

Rebecca’s journey with ovarian cancer began unexpectedly in 2001, when surgery intended for benign fibroid tumors lasted six hours and resulted in a radical hysterectomy and the shocking news that she had stage 2b ovarian cancer.

During STI Awareness Month, it is important to understand the complexities of sexually transmitted infections (STIs) that directly impact health and well-being. Among these, Human Papillomavirus (HPV) stands out as a pervasive infection because of its link to gynecologic cancers. 

The Payment Reform and Quality Care Subcommittee of HPSE recently published, “Early-career and Fellow Gynecologic Oncologists Perceive Underpreparedness for the Business of Medicine: A Society of Gynecologic Oncology Survey Study,” examining the impact of payment, reimbursement, and academic productivity in career decision-making for early-career (EC) attendings in gynecologic oncology.

Elizabeth Thayer, MD, of Emory University, is a recent recipient of the Foundation for Women’s Cancer (FWC) National Ovarian Cancer Coalition Research Award. Her research on ovarian cancer is deeply tied to patient care and the ongoing challenges of improving health literacy, particularly in gynecologic cancers.

Published in the March issue of Gynecologic Oncology, "An SGO Commentary: U.S. News and World Report gynecologic oncology procedural ratings," discusses the implications of endometrial and ovarian cancer ratings on quality of gynecologic care. 

The SGO Clinical Practice Committee recently published, “Germline and somatic testing for ovarian cancer: An SGO clinical practice statement,” intended to provide an overview of available testing modalities that can influence therapeutic decisions and care delivery for patients with epithelial ovarian cancer.

David Shalowitz, MD, MSHP, a Michigan-based gynecologic oncologist and past recipient of a Foundation for Women’s Cancer (FWC) grant (2021-2022), is a health equity researcher who is particularly committed to bridging the gynecologic cancer care gap in rural communities.